Today's technical alert includes important information for members in relation to a recent safety review of titanium dioxide. In Australian therapeutic goods, titanium dioxide is used in listed and registered medicines. In listed medicines, when used as an excipient, titanium dioxide is approved for use only as a colour and only in medicines limited to oral and topical routes of administration. Today's alert includes:
- Current information on EU activities
- Effect this could have on TGA and FSANZ activities relating to medicines and foods containing the ingredient
- Actions members should consider in relation to this information
- History of the considerations since 2016, as provided by IADSA
Please read the full alert for more details.